MEDIUM confidence: 100% data completeness, but the composite (55) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Not enough return history to estimate factor exposures — 29 of 36 months required. This stock is too recently listed (or has too short a price history) for a reliable Fama-French regression.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-08-30.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 14.4%/yr (revenue basis).
Base free cash flow $2.0B (avg FY2023–FY2025; latest year $3.7B) · equity value $225.7B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Avg target $1226 (last qtr, 7 analysts) → $1233 (last mo, 6) (+0.6%).
Buy-rated share 79% → 82% over ~3 months (+3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $4.03 | $4.81 | +19.4% |
| Jul 2026 | $3.17 | $2.47 | -22.1% |
| Apr 2026 | $1.95 | $17.44 | +794.4% |
| Jan 2026 | $2.93 | $13.39 | +357.0% |
| Oct 2025 | $1.72 | $1.64 | -4.7% |
| Jul 2025 | $1.48 | $1.86 | +25.7% |
| Apr 2025 | $0.47 | $0.91 | +94.2% |
| Jan 2025 | $2.28 | $1.73 | -24.1% |
Net insider -$7.0M over 180 days (0 open-market buys, 2 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $33.0B— | $29.7B-10.2% | $33.2B+12.1% | $34.9B+5.1% | $38.1B+8.9% |
| EPS (dil.) | $-2.33— | $-10.06n/m | $-1.61n/m | $5.58n/m | $17.69+217.0% |
| Free Cash Flow | -$2.2B— | -$627Mn/m | $442Mn/m | $1.7B+284.6% | $3.7B+118.3% |
| Gross Margin | 15.0% | 11.7%-3.3pp | 14.5%+2.8pp | 18.1%+3.6pp | 19.8%+1.7pp |
| Operating Margin | -2.7% | -9.7%-7.0pp | -2.8%+6.9pp | 2.3%+5.0pp | 3.6%+1.4pp |
| Net Margin | -1.9% | -9.2%-7.3pp | -1.3%+7.9pp | 4.4%+5.8pp | 12.8%+8.4pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
The QScore of 55 for GE Vernova Inc. suggests a neutral outlook, with the stock's strengths and weaknesses balancing out. The company scores high on growth and profitability, driven by strong revenue and earnings growth, as well as a high ROE of 85.6%. However, its value score is dragged down by premium multiples, including a P/E of 22.2 and P/B of 19.9, while momentum is also a concern due to a recent 3-month decline of 14.8% and a bearish moving average trend. The long-term and short-term scores are relatively aligned, indicating a consistent view of the stock's prospects.